MedPath

eonatal and placental genetic studies to find out the causes of intrauterine growth retardatio

Not Applicable
Conditions
Health Condition 1: O289- Unspecified abnormal findings on antenatal screening of mother
Registration Number
CTRI/2024/01/061243
Lead Sponsor
ICMR,New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.IUGR neonates diagnosed during pregnancies by antenatal ultrasound as abdominal Circumference < 10th percentile for gestational age after 20 weeks of gestation ) and no cause detected for IUGR

2. Mothers of these IUGR neonates

Exclusion Criteria

i. Multiple births

ii. Proven Intrauterine infection

iii. Major malformations

iv. Maternal chronic diseases

v. Identifiable syndromic neonate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Abnormalities in placental and neonatal microarray, <br/ ><br>2.Abnormal placental histopathology in idiopathic IUGR. <br/ ><br>3. <br/ ><br>5.Comparison with placentae from PE and healthy control mothers <br/ ><br> <br/ ><br>Timepoint: 18 months
Secondary Outcome Measures
NameTimeMethod
Maternal VEGF , PlGF and cord IGF1 and their correlations with birth weight and growth at 18 months. <br/ ><br>4.Abnormal insulin polymorphisms at birth and insulin resistance at 18 monthsTimepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath